Is schizophrenia just a mental illness? - The correlation between schizophrenia and cancer
DOI:
https://doi.org/10.12775/JEHS.2022.12.05.013Keywords
schizophrenia, cancer, risk of getting sickAbstract
Introduction and purpose of the work:Schizophrenia is a mental illness that affects approximately 24 million people worldwide. It is characterized by hallucinations, most often auditory, delusions, blunted affect, and distortions of thought, such as echoes of thought and perception. There is a predisposition to more frequent diabetes, metabolic syndrome, hormonal disorders, cardiovascular diseases and respiratory diseases, even in patients not treated with antipsychotics. In connection with the above, the question may arise whether schizophrenia also predisposes to developing other diseases, such as cancer. The aim of this article is to present the relationship between the occurrence of schizophrenia and cancer.
State of knowledge:There was no correlation between an increased incidence of lung cancer and schizophrenia, however, the analyzed studies were not homogeneous. In the case of breast cancer, data suggest a higher incidence of breast cancer among people with psychiatric disorders. In prostate cancer, a lower risk of developing the disease has been reported in patients with schizophrenia. It should be noted that despite the predisposition of people with schizophrenia to addiction to stimulants, low physical activity, the increase in the risk of cancer in some studies was not very high.
Summary: It can be noticed that there is a correlation between the occurrence of schizophrenia and the predisposition to developing malignant neoplasms. Currently, hope is placed on their use in anti-cancer therapy.
References
Schizophrenia. https://www.who.int/news-room/fact-sheets/detail/schizophrenia. Accessed 16 May 2022
Stilo SA, Murray RM (2019) Non-Genetic Factors in Schizophrenia. Curr Psychiatry Rep. https://doi.org/10.1007/S11920-019-1091-3
ICD-10 Version:2019. https://icd.who.int/browse10/2019/en#/F20-F29. Accessed 16 May 2022
Balhara YPS, Verma R (2012) Schizophrenia and suicide. East Asian Arch Psychiatry 22:126–133
Oud MJ, Meyboom-De Jong B (2009) Somatic diseases in patients with schizophrenia in general practice: their prevalence and health care. BMC Fam Pract. https://doi.org/10.1186/1471-2296-10-32
Dieset I, Andreassen OA, Haukvik UK (2016) Somatic Comorbidity in Schizophrenia: Some Possible Biological Mechanisms Across the Life Span. Schizophr Bull 42:1316–1319
Kritharides L, Chow V, Lambert TJR (2017) Cardiovascular disease in patients with schizophrenia. Med J Aust 206:91–95
Li H, Li J, Yu X, Zheng H, Sun X, Lu Y, Zhang Y, Li C, Bi X (2018) The incidence rate of cancer in patients with schizophrenia: A meta-analysis of cohort studies. Schizophr Res 195:519–528
Borovcanin MM, Vesic K (2021) Breast cancer in schizophrenia could be interleukin-33-mediated. World J psychiatry 11:1065–1074
Momen NC, Plana-Ripoll O, Agerbo E, et al (2020) Association between Mental Disorders and Subsequent Medical Conditions. N Engl J Med 382:1721–1731
Pettersson D, Gissler M, Hällgren J, Ösby U, Westman J, Bobo W V. (2020) The overall and sex- and age-group specific incidence rates of cancer in people with schizophrenia: a population-based cohort study. Epidemiol Psychiatr Sci. https://doi.org/10.1017/S204579602000044X
Korpela H, Miettunen J, Rautio N, Isohanni M, Järvelin M-R, Jääskeläinen E, Auvinen J, Keinänen-Kiukaanniemi S, Nordström T, Seppälä J (2020) Early environmental factors and somatic comorbidity in schizophrenia and nonschizophrenic psychoses: A 50-year follow-up of the Northern Finland Birth Cohort 1966. Eur Psychiatry. https://doi.org/10.1192/J.EURPSY.2020.25
Zhuo C, Zhuang H, Gao X, Triplett PT (2019) Lung cancer incidence in patients with schizophrenia: meta-analysis. Br J Psychiatry 215:704–711
Sagud M, Vuksan-Cusa B, Jakšic N, Mihaljevic-Peleš A, Kuzman MR, Pivac N (2018) Smoking in Schizophrenia: an Updated Review. Psychiatr Danub 30:S216–S223
Bushe CJ, Hodgson R (2010) Schizophrenia and cancer: in 2010 do we understand the connection? Can J Psychiatry 55:761–767
Viprey M, Pauly V, Salas S, Baumstarck K, Orleans V, Llorca PM, Lancon C, Auquier P, Boyer L, Fond G (2021) Palliative and high-intensity end-of-life care in schizophrenia patients with lung cancer: results from a French national population-based study. Eur Arch Psychiatry Clin Neurosci 271:1571–1578
Girardi P, Schievano E, Fedeli U, Braggion M, Nuti M, Amaddeo F (2021) Causes of mortality in a large population-based cohort of psychiatric patients in Southern Europe. J Psychiatr Res 136:167–172
Nordentoft M, Plana-Ripoll O, Laursen TM (2021) Cancer and schizophrenia. Curr Opin Psychiatry 34:260–265
Xiping Z, Shuai Z, Feijiang Y, Bo C, Shifeng Y, Qihui C (2019) Meta-analysis of the Correlation Between Schizophrenia and Breast Cancer. Clin Breast Cancer 19:e172–e185
Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371:569–578
Büschlen J, Berger GE, Borgwardt SJ, Aston J, Gschwandtner U, Pflueger MO, Kuster P, Radü EW, Stieglitz RD, Riecher-Rössler A (2011) Pituitary volume increase during emerging psychosis. Schizophr Res 125:41–48
Taipale H, Solmi M, Lähteenvuo M, Tanskanen A, Correll CU, Tiihonen J (2021) Antipsychotic use and risk of breast cancer in women with schizophrenia: a nationwide nested case-control study in Finland. The lancet Psychiatry 8:883–891
Andrade C (2021) Understanding the Limitations of the Odds Ratio in a Case-Control Study of the Association Between Breast Cancer and Exposure to Antipsychotic Drugs. J Clin Psychiatry. https://doi.org/10.4088/JCP.21F14319
De Hert M, Peuskens J, Sabbe T, Mitchell AJ, Stubbs B, Neven P, Wildiers H, Detraux J (2016) Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review. Acta Psychiatr Scand 133:5–22
Lu D, Song J, Lu Y, et al (2020) A shared genetic contribution to breast cancer and schizophrenia. Nat Commun. https://doi.org/10.1038/S41467-020-18492-8
Hwong A, Wang K, Bent S, Mangurian C (2020) Breast Cancer Screening in Women With Schizophrenia: A Systematic Review and Meta-Analysis. Psychiatr Serv 71:263–268
Chokhawala K, Stevens L (2022) Antipsychotic Medications. StatPearls
First-Generation Antipsychotics: An Introduction - Psychopharmacology Institute. https://psychopharmacologyinstitute.com/publication/first-generation-antipsychotics-an-introduction-2110. Accessed 20 May 2022
Mahar AL, Kurdyak P, Hanna TP, Coburn NG, Groome PA (2020) The effect of a severe psychiatric illness on colorectal cancer treatment and survival: A population-based retrospective cohort study. PLoS One. https://doi.org/10.1371/JOURNAL.PONE.0235409
Torrey EF (2006) Prostate cancer and schizophrenia. Urology 68:1280–1283
Mortensen PB (1992) Neuroleptic medication and reduced risk of prostate cancer in schizophrenic patients. Acta Psychiatr Scand 85:390–393
Hodgson R, Wildgust HJ, Bushe CJ (2010) Cancer and schizophrenia: is there a paradox? J Psychopharmacol 24:51–60
Ni L, Wu J, Long Y, Tao J, Xu J, Yuan X, Yu N, Wu R, Zhang Y (2019) Mortality of site-specific cancer in patients with schizophrenia: a systematic review and meta-analysis. BMC Psychiatry. https://doi.org/10.1186/S12888-019-2332-Z
Fond G, Macgregor A, Attal J, Larue A, Brittner M, Ducasse D, Capdevielle D (2012) Antipsychotic drugs: pro-cancer or anti-cancer? A systematic review. Med Hypotheses 79:38–42
Nordenberg J, Fenig E, Landau M, Weizman R, Weizman A (1999) Effects of psychotropic drugs on cell proliferation and differentiation. Biochem Pharmacol 58:1229–1236
Lianos GD, Alexiou GA, Rausei S, Galani V, Mitsis M, Kyritsis AP (2022) Repurposing antipsychotic drugs for cancer treatment: current evidence and future perspectives. Expert Rev Anticancer Ther 22:131–134
Avendaño-Félix M, Aguilar-Medina M, Bermudez M, Lizárraga-Verdugo E, López-Camarillo C, Ramos-Payán R (2020) Refocusing the Use of Psychiatric Drugs for Treatment of Gastrointestinal Cancers. Front Oncol 10:1452
Zhuo C, Xun Z, Hou W, et al (2019) Surprising anticancer activities of psychiatric medications: Old drugs offer new hope for patients with brain cancer. Front Pharmacol 10:1262
Elmaci I, Altinoz MA (2018) Targeting the cellular schizophrenia. Likely employment of the antipsychotic agent pimozide in treatment of refractory cancers and glioblastoma. Crit Rev Oncol Hematol 128:96–109
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Hubert Wróblewski, Dariusz Chojęta, Aleksandra Zimna, Ewelina Zygmunt, Kinga Wróblewska
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 475
Number of citations: 0